Total Receivables - Myriad Genetics Inc (NASDAQ:MYGN) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 22.955 USD 2.2%

Updated:

Myriad Genetics Inc
Total Receivables

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

Myriad Genetics Inc
Total Receivables Peer Comparison

ABBV

GILD

AMGN

VRTX

REGN

Company		Total Receivables	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Myriad Genetics Inc NASDAQ:MYGN	Total Receivables $118.1m	CAGR 3-Years 7%	CAGR 5-Years -4%	CAGR 10-Years 3%
	Abbvie Inc NYSE:ABBV	Total Receivables $11.9B	CAGR 3-Years 8%	CAGR 5-Years 16%	CAGR 10-Years 10%
	Gilead Sciences Inc NASDAQ:GILD	Total Receivables $4.7B	CAGR 3-Years 6%	CAGR 5-Years 7%	CAGR 10-Years 4%
	Amgen Inc NASDAQ:AMGN	Total Receivables $6.8B	CAGR 3-Years 15%	CAGR 5-Years 12%	CAGR 10-Years 10%
	Vertex Pharmaceuticals Inc NASDAQ:VRTX	Total Receivables $1.8B	CAGR 3-Years 22%	CAGR 5-Years 33%	CAGR 10-Years 40%
	Regeneron Pharmaceuticals Inc NASDAQ:REGN	Total Receivables $5.2B	CAGR 3-Years 8%	CAGR 5-Years 18%	CAGR 10-Years 17%

See Also

Based on the financial report for Mar 31, 2024, Myriad Genetics Inc's Total Receivables amounts to 118.1m USD.

Over the last year, the Total Receivables growth was -1%. The average annual Total Receivables growth rates for Myriad Genetics Inc have been 7% over the past three years , -4% over the past five years , and 3% over the past ten years .

Join more than 142,600+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.